NF-κB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro

Cell Proliferation

Volumn 42, Issue 2, 2009, Pages 150-161

  Zhang, Jiali ^a   Peng, Bin ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRITE; OCTAMER TRANSCRIPTION FACTOR 1; PROTEIN P50; SYNAPTOTAGMIN I; VASCULOTROPIN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NOS2A PROTEIN, HUMAN; TRANSCRIPTION FACTOR RELA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADENOID CYSTIC CARCINOMA; ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND CARCINOMA; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL LINE; CELL MOTION; CULTURE MEDIUM; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; SALIVARY GLAND TUMOR; TUMOR CELL LINE;

CARCINOMA, ADENOID CYSTIC; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; MUTATION; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; SALIVARY GLAND NEOPLASMS; TRANSCRIPTION FACTOR RELA; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 62549127310     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2009.00588.x     Document Type: Article

References (40)

1. AK EI-Nagh GER (2005) Adenoid cystic carcinoma. In : Barnes L, Eveson JW, Reichart P, Sidransky D, eds. Pathology and Genetics of Head and Neck Tumor, pp. 221 224. Lyon, France : IARC Press.
2. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407, 249 257.
3. Chen TG, Chen JZ, Wang XX (2006) Effects of rapamycin on number activity and eNOS of endothelial progenitor cells from peripheral blood. Cell Prolif. 39, 117 125.
4. Mizukami Y, Kohgo Y, Chung DC (2007) Hypoxia inducible factor-1 independent pathways in tumor angiogenesis. Clin. Cancer Res. 13, 5670 5674.
5. Onn A, Herbst RS (2007) Angiogenesis and lung cancer: implications for prognosis and treatment. Lancet Oncol. 8, 460 461.
6. Maulik N, Das DK (2002) Redox signaling in vascular angiogenesis. Free Radic. Biol. Med. 33, 1047 1060.
7. Stathopoulos GT, Kollintza A, Moschos C, Psallidas I, Sherrill TP, Pitsinos EN, Vassiliou S, Karatza M, Papiris SA, Graf D, Orphanidou D, Light RW, Roussos C, Blackwell TS, Kalomenidis I (2007) Tumor necrosis factor-α promotes malignant pleural effusion. Cancer Res. 67, 9825 9834.
8. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG (2002) The role of nitric oxide in cancer. Cell Res. 12, 311 320.
9. Zhang J, Peng B, Chen X (2005) Expressions of nuclear factor κB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin. Cancer Res. 11, 7334 7343.
10. Ishibashi H, Shiratuchi T, Nakagawa K, Onimaru M, Sugiura T, Sueishi K, Shirasuna K (2001) Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral. Oncol. 37, 77 83.
11. Younes MN, Park YW, Yazici YD, Gu M, Santillan AA, Nong X, Kim S, Jasser SA, El-Naggar AK, Myers JN (2006) Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model. Mol. Cancer Ther. 5, 2696 2705.
12. Zhang J, Peng B (2007) In vitro angiogenesis and expression of nuclear factor κB and VEGF in high and low metastasis cell lines of salivary gland adenoid cystic carcinoma. BMC Cancer 7, 95.
13. Baldwin AS Jr. (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649 683.
14. Blackwell TS, Christman JW (1997) The role of nuclear factor-κB in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 17, 3 9.
15. Colgate EC, Miranda CL, Stevens JF, Bray TM, Ho E (2007) Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-κB activation in prostate epithelial cells. Cancer Lett. 246, 201 209.
16. Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ, Van Wier S, Tiedemann R, Shi CX, Sebag M, Braggio E, Henry T, Zhu YX, Fogle H, Price-Troska T, Ahmann G, Mancini C, Brents LA, Kumar S, Greipp P, Dispenzieri A, Bryant B, Mulligan G, Bruhn L, Barrett M, Valdez R, Trent J, Stewart AK, Carpten J, Bergsagel PL (2007) Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma. Cancer Cell 12, 131 144.
17. 1 cell cycle arrest in primary hepatocytes. Cell Prolif. 40, 640 655.
18. Bharti AC, Aggarwal BB (2002) Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem. Pharmacol. 64, 883 888.
19. Ferrara N, Gerber HP, Lecouter J (2003) The biology of VEGF and its receptors. Nat. Med. 9, 669 676.
20. Guan XF, Qiu WL, He RG, Zhou XJ (1997) Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung: an experimental study. Int. J. Oral Maxillofac. Surg. 26, 116 119.
21. 1 integrin clustering and stimulates cell migration. Cancer Res. 62, 6837 6845.
22. Kalkunte S, Brard L, Granai CO, Swamy N (2005) Inhibition of angiogenesis by vitamin D-binding protein: characterization of anti-endothelial activity of DBP-maf. Angiogenesis 8, 349 360.
23. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M (2004) Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression. Cancer Cell 6, 297 305.
24. Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R, Gould D, Ayhan A, Balkwill F (2007) The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res. 67, 585 592.
25. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, Kelly RA (1999) Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 104, 271 280.
26. Kundu SD, Lee C, Billips BK, Habermacher GM, Zhang Q, Liu V, Wong LY, Klumpp DJ, Thumbikat P (2008) The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate 68, 223 229.
27. Tano T, Okamoto M, Oshikawa T, Ahmed SU, Sasai A, Sato M (2005) [Induction of apoptosis in human head and neck cancer cell lines by an active component of OK-432 through p53-independent pathway via toll-like receptor (TLR) 4 signaling]. Gan To Kagaku Ryoho 32, 1562 1564 (in Japanese).
28. Uehara A, Fujimoto Y, Fukase K, Takada H (2007) Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol. Immunol. 44, 3100 3111.
29. Kang S, Kim YB, Kim MH, Yoon KS, Kim JW, Park NH, Song YS, Kang D, Yoo KY, Kang SB, Lee HP (2005) Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer. Cancer Lett. 217, 11 16.
30. Karin M (2006) Nuclear factor-κB in cancer development and progression. Nature 441, 431 436.
31. Okamoto T, Yamagishi S, Inagaki Y, Amano S, Koga K, Abe R, Takeuchi M, Ohno S, Yoshimura A, Makita Z (2002) Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. FASEB J. 16, 1928 1930.
32. Fujioka S, Sclabas GM, Schmidt C, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ (2003) Function of nuclear factor κB in pancreatic cancer metastasis. Clin. Cancer Res. 9, 346 354.
33. Ohta T, Takahashi M, Ochiai A (2006) Increased protein expression of both inducible nitric oxide synthase and cyclooxygenase-2 in human colon cancers. Cancer Lett. 239, 246 253.
34. Chin K, Kurashima Y, Ogura T, Tajiri H, Yoshida S, Esumi H (1997) Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 15, 437 442.
35. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, Esumi H (2000) Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95, 189 197.
36. Sandau KB, Zhou J, Kietzmann T, Brune B (2001) Regulation of the hypoxia-inducible factor 1α by the inflammatory mediators nitric oxide and tumor necrosis factor-α in contrast to desferroxamine and phenylarsine oxide. J. Biol. Chem. 276, 39805 39811.
37. Yun CH, Yang JS, Kang SS, Yang Y, Cho JH, Son CG, Han SH (2007) NF-κB signaling pathway, not IFN-β/STAT1, is responsible for the selenium suppression of LPS-induced nitric oxide production. Int. Immunopharmacol. 7, 1192 1198.
38. Kim MJ, Ryu GR, Kang JH, Sim SS, Min DS, Rhie DJ, Yoon SH, Hahn SJ, Jeong IK, Hong KJ, Kim MS, Jo YH (2004) Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-κB activation. Biochem. Pharmacol. 68, 1775 1785.
39. Kawasaki K, Smith RS Jr., Hsieh CM, Sun J, Chao J, Liao JK (2003) Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol. Cell. Biol. 23, 5726 5737.
40. Fukumura D, Jain RK (1998) Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev. 17, 77 89.